ARCHIVES

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

This article is from The Cancer Letter archive.

Vol. 39 No. 30 | July 25, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

NCAB Approves Grants For Action Plan On Breast Cancer

September 22, 1995

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

NCI To Expand Funds for Cancer Centers, SPOREs, Director Tells House Appropriators

March 29, 2002